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Differences and similarities are examined among SARS-CoV-2, SARS-CoV-1, MERS and 
influenza A, in the context of transmissibility. Characteristics specific to the respective 
pathogens prove invaluable as they set the stage for intervention and management. SARS-CoV-2 
bears similarities to other recently emerged infectious diseases in basic virologic ways, yet is 
distinctly different in terms of viral transmission dynamics. These differences arise from 
genomic qualities and properties specific to the virus. As ACE2 receptors are determinants for 
attachment and spread of the virus, and their role throughout tissues in the body is vast, an 
understanding of organ-level pathogenesis of SARS-CoV-2 is crucial to effectively treat and 
(hopefully) neutralize SARS-CoV-2. Certain populations are identified as higher risk populations 
for severity of illness due to factors including age, gender and obesity. Therapies and treatments 






















A virus is not merely characterized by its genetic makeup, but also by its ability to infect, 
and the subsequent effects it has on respective host organisms. Transmissibility and 
symptomology vary among viral families in susceptibility of species affected, and severity of 
ensuing disease. An example of such can be seen in the onslaught of the recent novel severe 
acute respiratory syndrome coronavirus-2 (SARS-CoV-2); which has medical and scientific 
communities alike scrambling to accurately characterize and efficaciously treat this highly 
pathogenic organism. Understanding how this pandemic causing virus is alike or different from 
previously identified viruses is highly important for treatment and containment. As such, prior 
outbreaks of markedly contagious respiratory viruses, bearing similarities merit examination. 
Therapy and response to the SARS-CoV-2 pandemic is augmented by considering and 
comparing the fundamental characteristics of SARS-CoV-2 with SARS-CoV, MERS and 
influenza viruses.  
Background and Significance 
Viruses are responsible for multiple infectious processes, ranging from the common cold, 
to more severe illnesses like the flu (influenza A and B), middle east respiratory syndrome 
(MERS), severe acute respiratory syndrome (SARS or SARS-CoV), and of recent, COVID-19; 
caused by SARS-CoV-2 (CDC, 2020a). The genera that are responsible for the common cold are 
attributed to the alpha and beta coronavirus lineage, solely found in mammals (Biao et al., 2014). 
From the beta coronavirus lineage, MERS, SARS-CoV and SARS-CoV-2 arise (Lu et al., 2020). 
Considered extremely contagious and potentially pernicious diseases, these viruses are zoonotic 
in origin (passed from animal to human) (Hui & Peiris, 2019), yet are transmissible as human to 




human infections. Natural sources of these viruses were originally detected in dromedary camels 
(MERS), bats (MERS, SARS-CoV and SARS-CoV-2) (Lu et al., 2020), migratory birds, and 
pigs (novel influenza A) (Weber et al., 2016). Understanding the route by which a pathogen 
becomes viable in humans is but part of the task to contain and control an outbreak. A diseases’ 
transmissibility is also defined by the virus’s phylogeny, capacity (entry, replication, and 
virulence), transmission dynamics (type, contact and proximity), symptomology of the affected 
population, and stopgap therapies (screening, containment and human behaviors).  
Knowledge of virus origination is necessary in the control of transmission (Ypma, van 
Ballegooijen,  & Wallinga, 2013). Insight into viral evolution within a species enables inference 
of genomic morphisms, or reassortment events; as well as tracing ancestral lineage. Known as 
phylogenetic analysis, certain alterations are determined as likely given a species. Adjunctly, 
transmission modeling yields forecasting and epidemiologic surveillance. Models employing the 
recording of transmission events among infected hosts (transmission trees), and concurrent 
phylogenetic tree analysis (hereditary changes and traits), suggest conclusions about the 
organism and its host (Ypma et al., 2013). Such analyses are useful in the research of 
coronaviruses and influenza pathogens (Lei & Shi, 2011; Lu et al., 2020; Nelson & Worobey, 
2018). Phylogenetic findings indicate the infected animal sold in the Wuhan market was an 
intermediate or connecting link, facilitating the animal to human transmission (Chan et al., 2020; 
Lu et al., 2020; Weber et al., 2020). The idea of an intermediate host, is also considered the case 
in SARS-CoV (Lu et al., 2020; Schnieder, 2012), MERS (van Doremalen et al., 2014) and 
several strains of human influenza A (Lei & Shi, 2011; Zhao et al., 2019). 
 The capacity of a virus is apparent in its ability to attach, enter, and replicate; and in its 
virulence. For successful fusion and entry of target cells, influenza A viruses (FLUAVs), rely on 




the binding properties of the glycoprotein hemagglutinin (HA); while SARS-CoV-1, SARS-
CoV-2,  and MERS rely on the spike (S) surface proteins (Lu et al., 2020; Zmora et al., 2014). 
Facilitated via phylogenetic analysis, researchers determined the receptor-binding domain (RBD) 
of SARS-CoV-2 as comparable to that of SARS-CoV-1 (Lu et al., 2020). Once these viruses 
enter the body, they locate target cells expressing select receptors to which they attach and bind. 
After fusion, and for the given virus to enter the host cell, activation of the HA (FLUAV), or S 
(coronavirus) proteins must occur. Activation occurs when HA and S proteins respectively, are 
cleaved by proteolytic enzymes known as proteases, found on the host cells (Lu et al., 2020; 
Zmora et al., 2014). Serving as such a determinant, the enzyme TMPRSS2, activates and 
facilitates entry for several subtypes of the influenza A virus, as well as coronaviruses 
(Bourgonje et al., 2020; Zmora et al., 2014). Once inside the host cell, all the necessary 
machinery is at the disposal of the virus for replication. The virus exploits the translation 
apparatus of the host cell to produce the necessary structural and non-structural proteins 
necessary for sabotage. These proteins equip the virus for evasion of innate immune system cells, 
and induce harmful effects detrimental to appropriate cellular response and functioning (Astuti & 
Ysrafil, 2020; Wang et al., 2020). 
The dynamics for transmission of these viruses is somewhat variable. The MERS 
outbreak in 2012, was spread by droplet and contact transmission, with the highest number of 
cases noted among health care workers. The lower respiratory tract was notably affected by 
MERS; and demonstrated significantly higher viral loads on culture and analysis than the upper 
respiratory tract (Bradley & Bryan, 2019; Corman et al., 2016; NCIRD, 2019). The case fatality 
rate (CFR) of MERS was reported at 35%, with a low probability of manifestation in children 
(Bradley & Bryan, 2019).  




SARS-CoV-1 was spread by droplet, contact, and airborne (or aerosol) processes; 
replication was most pronounced in the lower respiratory tract (Chan et al., 2020) as well. In the 
case of both SARS-CoV-1 and MERS, a higher viral load was consistent with symptom 
presentation; with a mean peak of viral load 7-10 days after the onset of illness (To et al., 2020). 
Reported CFR of SARS-CoV-1 was 9.6 - 11%; and similar to MERS, children were not often 
affected (Bradley & Bryan, 2019; Weber et al., 2015).   
Viral shedding for MERS and SARS-CoV-1 was described in tracheal, nasopharyngeal, 
and nasal swabs; and stool and urine samples (Corman et al., 2016; Bradley & Bryan, 2019). The 
persistence of the viral fragments in feces suggested oral-fecal potential for contact infectivity 
(Bradley & Bryan, 2019; Ong et al., 2020). While the amount of time respective viruses are 
viable varies, based on both the ambient and physical environment (temperature, relative 
humidity, surface type, and relative air flow), coronaviruses potentially maintain high-levels of 
infectivity (Lei et al., 2018; Ong et al., 2020; van Doremalen et al., 2020). 
SARS-CoV-2 is primarily transmitted through respiratory droplets (Guan et al., 2020); 
though it also spreads via contact and airborne (or aerosol) modalities. In contrast to MERS and 
SARS-CoV-1, SARS-CoV-2 replicates most abundantly in the upper respiratory tract (To, et al., 
2020; Zou, Guan et al.,  2020).  
To et al. (2020), theorized that as a result of both high viral thresholds (early in the 
disease onset) and the estimated high percentage of asymptomatic shedders, SARS-CoV-2 has 
spread much quicker than either the MERS or SARS-CoV-1 viruses. Another compounding 
factor is that testing is often inadequate, unavailable or numbers are under-reported (Li et al., 
2020). To demonstrate the ease and speed by which SARS-CoV-2 has spread, at the time of 
initial writing of this paper, June 2, 2020, the CFR was 5.9% globally (377,460 deaths/6,325,303 




confirmed cases), and 5.8% in the United States (105,644 deaths/1,820,523 confirmed cases) 
(JHU CSSE, 2020). A mere 7 weeks later, July 21, 2020, the CFR is 4.1% globally (618,994 
deaths/15,033,861 confirmed cases), with the number deaths up 64%, and confirmed cases 
almost 2.4 times higher. The United States CFR dropped to 3.6% (142,595 deaths/3,935,211 
confirmed cases), with the number of the number of deaths up 35%, and confirmed cases almost 
2.2 times higher (JHU CSSE, 2020). 
Symptoms vary widely among confirmed cases, with severity of symptoms and poor 
outcome increasing in a directly proportional nature to increased age (over 65) and number of 
comorbidities. However, the disease is also indiscriminate, afflicting all age groups and 
minorities (although less frequently found in children under 18 years of age) (CDC, 2020b, 
CDC, 2020c).  
Influenza A is transmitted primarily through inhalation and contact (Hui & Peiris, 2019; 
Lei et al., 2018; Weber et al., 2016), and has a CFR in the U.S. of about 0.1% annually. Influenza 
replicates predominantly within the lower respiratory tract similar to SARS-CoV-1 and MERS 
(Bradley & Bryan, 2019). Populations hardest hit are those over the age of 65, and those least 
severely affected are represented in the 5-17-years age group (CDC, 2020a). 
As SARS-CoV-2 and influenza A exhibit likeness in nature symptomatically, 
differentiation for diagnosis without further diagnostics is challenging. In SARS-CoV-2 as is the 
case in influenza, fever, generalized malaise or fatigue, and cough or pharyngeal pain are 
common manifestations (Wang et al., 2020). However, as was reported by Guan et al. (2020), 
only 44% of those patients presenting (positive for COVID-19), had a fever with initial clinical 
evaluation. As SARS-CoV-2 patients often express the disease in varying degrees of severity, 
while difficult, an accurate diagnosis is extremely important. Therefore, CT scans are considered 




of significant value for additional information and differentiation (Guan et al., 2020; To et al., 
2020; Wang et al., 2020). 
While identification, containment and supportive care are necessary early triage 
measures, long-term community health controls are imperative (Bourgonje et al., 2020; NCIRD, 
2020a), for sustained public health (NCIRD, 2020b). For the community at large, and researchers 
in particular, a fundamental understanding of viral origin and transmission play an integral part 
in treatment and prevention. Scientists employ foundational knowledge and domain expertise of 
the viruses, their structure, function, and activity, in their iterations of prophylactic treatments. 
This review examines the question of how the SARS-CoV-2 contagion differs 
fundamentally in transmissibility, symptomology and characteristics from SARS-CoV, MERS 
and the influenza viruses based on existing literature to date. 
Methods 
Literature Search 
Relevant literature was searched via the following databases: Academic Search Complete 
(ASC), Cumulative Index of Nursing and Allied Health Literature (CINAHL), PubMed, and 
Scopus, for the period between January 2010, to June 2020. Keywords used to retrieve the 
articles included: ‘coronavirus’ OR ‘COVID-19’ OR ‘2019-nCoV’ OR  ‘SARS-CoV-2’, AND 
‘SARS’ OR ‘Severe Acute Respiratory Syndrome’, AND ‘MERS’ OR ‘Middle East Respiratory 
Syndrome’, AND ‘influenza’ OR ‘flu virus’ OR ‘influenza A’, AND ‘transmission’ OR 
‘transmissibility’ OR ‘spread’. Results were imported into RefWorks where titles were perused 
and duplicate entries were removed via the software tools. See Appendix A, Figure 1 for 
preferred reporting items for systematic review diagram (Moher et al., 2009). 
Exclusion and Inclusion Criteria 




Specifications on searches were designed to return peer-reviewed, published, English 
language, full-text records, including journal articles or books. Of the records returned, titles and 
abstracts were examined to determine applicability to the research question. Non-pertinent 
articles were removed. Several literature and systematic reviews were returned in the original 
search. These were examined to identify potential relevant gray literature, and two reviews were 
included for terminology explanation (Astuti & Ysrafil, 2020; Hui & Peiris, 2019). Of the 
records extracted, likeness and differences among MERS, SARS-CoV-1, SARS-CoV-2, and 
influenza were evaluated. Characteristics of interest included: origin, structure, function, 
transmission dynamics (cellular and human to human transmission), symptomology, virulence of 
the pathogen, and persistent viability of the virus(es) outside the body. 
Meta-analysis 
 There is some overlap in use of the manuscripts for the topics of interest. Of the 
manuscripts examined, three evaluated origin, lineage, and relevance of genome analysis in the 
explanation of viral transmission (Biao et al., 2014; Lu et al., 2020; Ypma et al., 2013). Seven 
studies assessed zoonotic commonalities of the diseases, and corresponding intermediate hosts 
(Lei & Shi, 2011; Morse, 2012; Nelson & Worobey, 2018; Schnieder, 2012; van Doremalen et 
al., 2014; Weber et al., 2020; Zhao et al., 2019). Five manuscripts analyzed viral tropism, the 
ability of the virus to infect certain cells based on the type of cell/tissue and expression of select 
necessary receptors (Bourgonje et al., 2020; Hui et al., 2020; Lu et al., 2020; Tai et al., 2020; 
Zmora et al., 2014). The processes of viral infectivity and pathogenesis were described in six 
studies (Bourgonje et al., 2020; Bradley & Bryan, 2019; Corman et al., 2014, Ding et al., 2004; 
Li et al., 2020; Sanche et al., 2020; Wang et al., 2020). The structure and function of viruses is 
explained in an overview by Astuti & Ysrafil (2020). Eight articles reported findings relative to 




degree of infectivity, as determined by viral load, viral shedding and body fluids (Chan et al., 
2020; Corman et al., 2020; Du et al., 2020; Hui et al., 2020; Schnieder, 2012; To et al., 2020; 
Watson, Whiting, & Brush, 2020; Zou et al., 2020). Six studies discussed immune response and 
patient symptomology (Bourgonje et al., 2020; Bradley & Bryan, 2019; Guan et al., 2020; 
Schnieder, 2012; Wang et al., 2020; Watson et al., 2020). Viral persistence and relative stability 
in external environments were assayed by researchers in four studies (Chan et al., 2020; Lei et 
al., 2020; Ong et al., 2020; van Doremalen et al., 2020). And finally, therapy and treatments to 
date were outlined in seven studies (Du et al., 2020; Hui & Peiris, 2019; Ong et al., 2020; 
Schnieder, 2012; Tai et al., 2020; van Doremalen et al., 2014; Zmora et al., 2014). 
Of the studies selected, fifteen occurred in China (Du et al., 2020; Hui et al., 2020; Hui & 
Peiris, 2019; Guan et al., 2020; Lu et al., 2020; Ong et al., 2020; To et al., 2020; Wang et al., 
2020; Zhao et al., 2019; Zou et al., 2020); with all but five occurring from December 2019 – 
February 2020 (Biao et al., 2011; Chan et al., 2011; Ding et al., 2004; Lei & Shi, 2011;  Lei et 
al., 2018). Two studies originated from The Netherlands (Bourgonje et al., 2020; Ypma et al., 
2013); one from Germany (Zmora et al., 2014); seven were from the United States (Bradley & 
Bryan, 2019; Nelson & Worobey, 2018; Sanche et al., 2020; Schnieder, 2012; van Doremalen et 
al., 2014; van Doremalen et al., 2020; Weber et al., 2020); one from Saudi Arabia (Corman et al., 
2014); one from Indonesia (Astuti & Ysrafil, 2020); the other four were collaborations among 
the U.S., China, Switzerland, and the UK, or a combination therein (Li et al., 2020; Morse et al., 
2012; Tai et al., 2020; Watson et al., 2020). 
Results 
The following section describes the results in a theme based, sequential fashion designed 
to orient the reader to the system of transmission. This includes: a limited description of origin 




and evolution, capacity, transmission dynamics, affected population symptomology and 
current/evolving interventions and therapies. 
Origin, Lineage, Genome Analysis and Phylogenesis 
 In the recent SARS-CoV-2 outbreak, scientists analyzed genome sequencing of viral 
samples obtained from an infected population segment known to have attended the Hunan 
market in Wuhan, to delineate ancestral history of the coronavirus genomes (Lu et al., 2020). 
Phylogenetic modeling of the viral samples enabled scientists to gain insight into the sequence 
evolutionary order, thus facilitating source determination (Guan et al., 2020; Lu et al., 2020; 
Ypma et al., 2013). Their findings indicated closely related genome sequences to coronaviruses 
found in bats – reportedly, 88% identical (Chan et al., 2020; Lu et al., 2020). The genome 
sequences, while similar, were noted to be less alike SARS-CoV-1 and MERS-CoV 
(corresponding 79% and 50%, respectively) (Lu et al., 2020). Patient cohort viral samples whole-
genome sequenced in another study supported ancestral findings; while informing researchers of 
possible mutations occurring amid infection. Evaluation of the cluster revealed no 
polymorphisms in 21% (4 of 19) of patients evaluated (To et al., 2020). Phylogenetic analysis 
has also been instrumental in mapping the spread and transmission of H5N1 influenza; 
propagated by wild birds and their migratory patterns (Lei & Shi, 2011). 
Zoonosis and Intermediate Hosts 
 The emergence of diseases not previously seen in humans is attributed to various 
explanations. Natural dwellings for wildlife face continual disruption as community expansion 
progresses and populations grow; the increased propensity of people to travel and ability to 
access remote areas; a higher possibility of interaction between wild animals and humans; and 
disruption of predator/prey balance leaving populations more susceptible to exposure (Karesh et 




al., 2012; Morse et al., 2012; Weber et al., 2016)). Noteworthy, only a marginal percentage of the 
COVID-19 positive patients reported direct contact with wildlife (Guan et al., 2020). Similar 
findings were noted in regard to contraction of MERS and camels (van Doremalen et al., 2014). 
In the case of the SARS-CoV-1outbreak, antibody levels assayed were found to be slightly 
elevated in wildlife traders (Schnieder, 2012). 
In regard to SARS-CoV-2, scientists asserted several aspects for consideration. While 
bats have been implicated as the natural reservoir species for SARS-CoV-1 (Biao et al., 2014; 
Schnieder, 2012); MERS (Hui & Peris, 2019; van Doremalen et al., 2014), and SARS-CoV-2 
(Lu et al., 2020), certain factors suggest an intermediate host played an integral part in the 
transmission to humans (Biao et al., 2014).  The viral S protein, responsible for receptor binding 
to the ACE2 was analyzed as dissimilar enough that direct infection from bats to human was not 
supported (Biao et al., 2014). Also, at the seafood market where the SARS-CoV-2 outbreak was 
determined to originate, bats were not present. Winter, the season when COVID-19 cases were 
first reported, coincided with bats’ hibernation cycle (Lu et al., 2020). The mammals at the 
market included known carriers of prior SARS-CoV-1 disease (masked palm civet), (Biao et al., 
2014); and the genomic similarity, while assessed as close (88% identical), was dissimilar 
enough to disqualify bats as a preliminary infector of humans (Lu et al., 2020). Palm civets 
however, when genomically sequenced, showed 99.8% likeness to the SARS-CoV-1 human 
genome (Biao et al., 2014), and thus inferred them as the animal source. 
 Determination of a MERS intermediate host prompted researchers to investigate food 
source origins (van Doremalen et al., 2014). Contamination of un-pasteurized dairy products 
(camel, goat or cow milk) was postulated as a potential link in this contagion’s outbreak, as un-
pasteurized products were known to be regularly consumed by people of the Arabian Peninsula 




(van Doremalen et al., 2014). It remains unknown if the virus can be excreted into the milk, or if 
consumption of contaminated milk results in infection. However, MERS was shown to survive in 
un-pasteurized milk for considerable periods of time. Furthermore, pasteurization was shown to 
eliminate the infectious virus (van Doremalen, et al., 2014). 
For many years, influenza researchers considered pigs as applicable “mixing vessels”, 
and intermediate hosts for various infectious avian flu strains in humans; highly due to receptors, 
associated linkages, and purported recombinant changes (Lei & Shi, 2011; Nelson & Worobey, 
2018). With exception of the 2009 H1N1 pandemic, this compelling theory is not conclusively 
supported. In the 2009 H1N1 pandemic, swine to human transmission was deduced as a result of 
retained circulating genomic fragments from previous avian-hosted viral infections, engaging 
with other viruses in reassortment events; thus, creating a new strain (Nelson & Worobey, 2018). 
What is intriguing, is the opposite directionally (human-swine transmission), and variability of 
lineage has been conferred (Nelson & Worobey, 2018). Evidence indicates humans are more 
consequential to swine, than swine are to humans (and swine are not likely avian intermediates 
for most influenza strains that infect humans). Furthermore, swine-human infections are limited, 
and not promotive of persistent human-human transmission (Nelson & Worobey, 2018). 
Riverside and semi-aquatic mammals like minks, are also theorized to serve as potential mixing 
vessels, and contributory reservoirs for flu viruses. In the presence of other viral co-infections, it 
is thought, that viral genesis via reassortment events is possible subsequently facilitating 
interspecies transmission (Zhao et al., 2019). 
Viral Tropism 
 In the case of SARS-CoV, MERS, SARS-CoV-2 and influenza viruses, productive 
infection of cells is highly receptor dependent. ACE2 receptors, expressed in varying degree of 




numbers throughout tissues in the body (Astuti & Ysrafil, 2020; Bourgonje et al., 2020), are 
determinant receptors for SARS-CoV-1, MERS (Zmora et al., 2014), and SARS-CoV-2 
(Bourgonje et al., 2020; Hui et al., 2020; Tai et al., 2020). SARS-CoV-1 and SARS-CoV-2 
secure attachment to ACE2 receptors via binding with the RBD of spike (S) surface proteins. 
Exploitation of molecular structure and properties is used as researchers design vaccines that 
function as inhibitors of viral attachment (Astuti & Ysrafil, 2020; Tai et al., 2020). For viral 
activation, post cellular adherence, specific serine proteases (TMPSSR2 among others 
described), (Zmora et al., 2014), cleave S proteins which in turn trigger morphological adaption 
of the virus and subsequent entry into the target cell (Astuti & Ysrafil, 2020; Bourgonje et al., 
2020; Lu et al., 2020; Zmora et al., 2014). In the case of influenza A viruses, binding of 
hemagglutinin (HA) protein depends on sialic acid expression on target cells (Lei & Shi, 2011; 
Nelson & Worobey, 2018); while activation and cleavage rely on the proteolysis mechanism as 
described above (Zmora et al., 2014). In order to take advantage of this mechanism, protease 
inhibitor drugs are designed pharmacodynamically to both decrease severity and improve 
outcome (Bourgonje et al., 2020; Hui & Peris, 2019) by blocking the actions of the proteases.  
Transmission Dynamics 
Transmission dynamics, how the virus is spread human to human, rely heavily on the 
mechanism of release, host susceptibility and requisite receptors. Specifically, host attributes like 
viral load (the concentration of pathogens in a body fluid) and viral shedding, influence and 
potentiate transmission. 
Viral infectivity and pathogenesis. Cellular pathogenesis of SARS-CoV-2 and SARS-
CoV-1 depend on tissue type, and degree of ACE2 receptor regulation (Astuti & Ysrafil, 2020; 
Bourgonje et al., 2020). ACE2 receptor expression is highly prevalent throughout the body, yet 




not all organs suffer the same degree of injury. Initial infection occurs predominantly via mucous 
membranes of the nose and mouth, and conjunctiva of the eyes (Bourgonje et al., 2020; Hui et 
al., 2020). These portals offer direct access to the upper and lower respiratory tract. The lining of 
the bronchus and alveoli are rich with epithelial cells, where ACE2 receptors are profusely 
expressed; providing ample opportunity for infection to seed. From there, access to the 
bloodstream by way of the capillary beds perfusing the alveoli of the lungs, is but a short trip;  
and the infection then spreads systemically to other organs (Astuti & Ysrafil, 2020; Bourgonje et 
al., 2020). Interestingly, influenza A infection has been shown to result in an upregulation 
(increase in surface cell receptor expression) of ACE2 receptors, in cells such as those in alveolar 
epithelium. As a result, subsequent infection with SARS-CoV-2 might result in a potentiated 
adverse outcome and greater infectivity (Hui et al., 2020). The GI tract is thought to be 
vulnerable by way of the oral cavity directly, or oral/fecal route (Bourgonje et al., 2020; Hui et 
al., 2020; Ong et al., 2020; Schnieder, 2012). 
Most notably affected, are cells of the upper and lower respiratory tract, heart, kidneys, 
bladder, biliary tract, ileum and colon (Astuti & Ysrafil, 2020; Bourgonje et al., 2020; Hui et al., 
2020). This is consistent with the symptomology manifested by patients and discussed later. The 
pathogenesis of SARS-CoV-2 in adipose tissue is also thought to largely contribute to the 
systemic inflammatory response that plagues many patients and ultimately confers a degree of 
severity. ACE2 receptors are amply found in visceral fat (fat located in the intra-abdominal 
cavity), and consistent with obesity. Found within these adipocytes are adipokines, essential 
regulators in a system of pathways important to metabolism and proper organ functioning 
(Bourgonje et al., 2020; Kwon & Pessin, 2013). In obesity, pro-inflammatory expression of 
adipokines (specifically leptin) is increased, which results in metabolic and endocrine 




imbalances, and augmented inflammatory response (Kwon & Pessin, 2013). Of patients reported 
to experience more severe disease, and in need of ICU admission, or who ultimately died, BMI 
was found to be > 25kg/m2 (cited in text of Peng et al., 2020 by Bourgonje et al., 2020). 
Relative  infectivity of a virus; viral load, shedding (body fluids). Knowledge of 
optimal tissue implantation by the virus in propagation, reveals the intensity, and in part, how the 
virus is shed (Hui et al., 2020). Shedding of the virus corresponds to the time in which patients 
are considered infectious. Viral loads in MERS were serologically detectable 1 week after the 
initial onset of symptoms. SARS-CoV-1 had like findings, with 79% of cases positive for 
viremia one week out; and 50% positive 2 weeks out (Corman et al., 2014). Neither MERS nor 
SARS-CoV-1 were thought to be transmitted by the blood, as MERS virus could not be isolated 
from the serum, and only very low levels of replicating virus were found in SARS-CoV-1 patient 
blood samples (Corman et al., 2014). Interestingly, neutralizing antibodies were documented in 
the presence of viremia in MERS, indicating the mounted antibody response was inadequate to 
overcome the infection. While most patients seroconverted in the first 1-2 weeks with MERS, 
upwards of 45% of fatal cases, reported in one study, lacked an antibody response (Corman et 
al., 2014). Viral load shedding peak for SARS-CoV-1 and MERS was determined at 10-12 days 
post initial symptoms (Corman et al., 2014; Hui & Peris, 2020; Schnieder, 2012). In contrast, 
SARS-CoV-2 viral shedding measured highest (in upper respiratory tract specimens) within the 
first week post-symptom onset, decreasing thereafter (To et al., 2020; Zou, Ruan & Huang, 
2020).  
Researchers also determined, that the viral loads of patients with SARS-CoV-2 who were 
asymptomatic, were analogous to the viral loads measured in those who were symptomatic (Zou 
et al., 2020). The viral load profile is similar to that of influenza, which also peaks close to onset 




of symptoms (To et al., 2020; Zou et al., 2020). While viral peak load and age were shown to be 
positively correlated (To et al., 2020), viral load was not correlated with severity of the disease 
reported for either MERS or SARS-CoV-2 (Corman et al., 2014; To et al., 2020). However, 
disease severity was shown to be more pronounced for older patients (Bourgonje et el., 2020; 
Guan et al., 2020). High viral loads lacking severity is supported by the high degree of 
asymptomatic and mildly symptomatic SARS-CoV-2 patients considered highly contagious early 
in the disease process (Zou et al., 2020). Additionally, prolonged shedding in SARS-CoV-2 has 
been documented up to 20 days post-onset of illness (To et al., 2020).  
Replication competence of SARS-CoV-2 is reported as analogous to MERS, while 
replicating more profusely than SARS-CoV-1 in the epithelium of the bronchus and the 
conducting airways (Hui et al., 2020), but similarly in the alveolar epithelium as SARS-CoV-1.  
One study indicated SARS-CoV-2, SARS-CoV, H1N1 and H5N1 demonstrated similar 
replication competence in colorectal cells, yet lower replication competence than MERS (Hui et 
al., 2020); conversely, reported findings of Corman et al. (2014); recorded a smaller percentage 
of patients with positive MERS RNA in stool samples, than those patients having stool samples 
positive for SARS-CoV-1. SARS-CoV-1 was also isolated in sweat glands, but findings were 
non-conclusive as to whether sweat itself was an applicable mode of transmission (Ding et al., 
2004). 
The reproduction number of these diseases (R0), refers to degree of infectivity of an 
infected individual has, or will have, during the period in which they are actively contagious. 
This metric can vary considerably early in the contagion, and prior to active contact tracing of 
infectors; but is imperative in modeling and for implementation of interventions (Du et al., 
2020). The reproductive number for SARS-CoV-2 is highly variable in estimates; ranging from 




1.32-5.8 (cases) (Bourgonje et al., 2020; Du et al., 2020; Li et al., 2020; Sanche et al., 2020). 
This number depends not only on the time in the outbreak when it is estimated and where, but 
also on travel, social restrictions and personal interventions; latency and incubation period; and 
the corresponding calculated serial interval (SI) (time between infector onset of symptoms and 
subsequent report of symptoms from person infected) (Bourgonje et al., 2020; Du et al., 2020; 
Sanche et al., 2020); In the case of SARS-CoV-2, a lower R0 corresponds to a shorter SI, while a 
higher R0 corresponds to a longer SI (Sanche et al., 2020). As reported by Li et al. (2020), the R0 
was higher early in the outbreak (2.38), and with few or no travel restrictions imposed; an SI of 
7-8 days (Li et al., 2020; Sanche et al., 2020), and mean incubation period of 4 days (Guan et al., 
2020).  In comparison, the R0 for SARS-CoV-1 was reported as 3 (Schnieder, 2012); with an 
incubation period mean of 2.6 days; MERS R0 <1; mean incubation period of 5 days (Weber et 
al., 2020); and influenza (pandemic) R0 =  1.8 (Soucheray, 2020); reported incubation period 
mean of 2 days. 
Immune Response, Patient Symptomology & Diagnosis 
Symptoms may be non-existent, mild or severe in SARS-CoV-2, depending on an 
individual’s viral profile, comorbidities (underlying disease, age, obesity, disease processes) and 
prolonged exposure (Bourgonje, 2020). For patients aged >60, there is increased severity of 
illness/complications (Bourgonje et al., 2020; Guan et al., 2020). Underlying co-morbidities 
further increase the risk for progression to a severe form of this illness. These findings are also 
applicable to MERS, SARS-CoV-1, and influenza (Bourgonje et al., 2020; Schnieder, 2012; To 
et al., 2020). Reportedly 10-20 percent of patients infected with SARS-CoV-2 go on to develop a 
severe form of the illness requiring either ICU admission, and mechanical ventilation. 




Additionally, men are noted to be at higher risk for increased severity. This is thought to be due 
to higher ACE2 levels in men (Bourgonje et al., 2020). 
Research of explanted tissue samples of positive SARS-CoV-2 patients suggests that the 
cytokine response in SARS-CoV-2 is less potent than that which occurs in H1N1, H5N1 or 
MERS (Hui et al., 2020). Reported symptoms of SARS-CoV-2 are also seen in influenza; fever, 
cough, headache, fatigue, generalized malaise, shortness of breath and chest pain; although GI 
upset is less common (inclusive of diarrhea and nausea) in SARS-CoV-2 (Bourgonje et al., 2020; 
Wang et al., 2020). Coagulopathy is also apparent for many COVID-19 patients which 
corresponds to a heightened inflammatory process and an increased risk of death (Bourgonje et 
al., 2020). Prior reported cases of SARS-CoV-1 and MERS patients exhibited neurologic 
involvement thought due to viral invasion in the brain (Bourgonje et al., 2020). The extent to 
which SARS-CoV-2 attacks brain cells is uncertain, but considered likely due to the ACE2 
receptors on various neural cells and neurologic symptoms (Bourgonje et al., 2020). 
 While real time polymerase chain reaction (RT-PCR) immunoassays are used for 
diagnosis, accuracy of tests is questionable in sensitivity (Wang et al., 2020). A negative swab 
test (even in the presence of symptoms) reportedly occurs between 2- 29% of the time (Watson 
et al., 2020). Thus, additional diagnostic support is indicated to improve accuracy and treatment 
via the use of CT scans. CT enables differentiation of influenza to SARS-CoV-2 in characteristic 
appearance of key findings (Wang et al., 2020). In influenza, abnormalities primarily of the 
inferior lobes are involved; whereas in SARS-CoV-2, in multiple lobes and throughout the lungs, 
infection is noted. Pulmonary lesions are found in inferior lobes in influenza; while more non-
specific distribution, and a higher number of lesions are seen in SARS-CoV-2. Margin lesions 
are vague in influenza induced pneumonia; while clear pulmonary lesion margins are denoted in 




SARS-CoV-2. Finally, there is a shrinking contour appearance of the lungs in SARS-CoV-2, and 
consistent ground-glass opacity described (Bourgonje et al., 2020; Guan et al., 2020; Wang et al., 
2020).  
Viral Persistence & Stability 
 SARS-CoV-1, when assayed on inanimate surfaces, was most stable in temperate 
environments with relatively low humidity, while high temperatures and high humidity did not 
support viability. A relative humidity of 40-50% and temperature range of 22-25 degrees 
Celsius, was shown as most supportive of SARS-CoV-1, and promoted virus viability for 2-5 
days. As temperature and humidity fluxed upward, viability was demoted (Chan et al., 2011). 
Prolonged exposure time, recycled ventilation, and contact with fomites increased infectivity 
persistence and risk of exposure for SARS-CoV-1, influenza, and norovirus in a mathematically 
modeled study analogous to cabin air-flow and inflight exposure (Lei et al., 2018). Other studies 
validate findings that transmission of coronaviruses via contaminated surfaces is prolonged; and 
the degree of contamination of a surface, is not necessarily dependent on severity of illness 
exhibited by the infected individual (Ong et al., 2020). Finally, plastic and stainless-steel support 
stability longer for SARS-CoV-2 (respective half-lives of 5.6 and 6.8 hours), than do other 
surfaces; and could still be detected on surfaces 72-hours after the viral application (van 
Doremalen et al., 2020).  
Therapy and Treatments 
 Treatment of viral infectivity has been suggested through use of some current therapies. 
Other developing modalities are based on viral mechanics. Development of prospective protease 
inhibitors (preventing cleavage and subsequent activation) (Weber et al., 2020; Zmora et al., 
2014); and proposed RBD protein inhibitor vaccine (blocking viral attachment) (Astuti & 




Ysrafil, 2020; Tai et al., 2020) are anticipated. Current therapies either indicated or employed 
include: enhancing immune response through immunomodulators and anti-inflammatories 
(management of cytokine and inflammatory response); anti-viral drugs that target action of the 
RNA polymerase (effectively inhibiting synthesis of viral RNA); ACE inhibitor drugs (blocking 
the receptors necessary for viral attachment and entry), anti-coagulants (preventing thrombotic 
blood clots); antibiotics (for concomitant bacterial infections), and support of gas exchange and 
oxygenation (Bourgonje, et al., 2020; Du et al., 2020; Guan et al., 2020; Hui & Peris, 2019). At 
present, public health campaigns stress prevention as the primary route to control the contagion 
(CDC, 2020d). 
 Research expounding on the differences and similarities for the contagions mentioned 
above is key to control of the SARS-CoV-2 pandemic. The results of these studies explain 
cellular interaction, tissue pathogenesis and physiological regulation in response to viral 
invasion, and ultimately enhance the basic understanding of transmissibility essential for 
efficacious therapy, treatment and control of SARS-CoV-2. 
Discussion 
Scientific knowledge and heightened awareness greatly affect the systematic approach, 
personal behaviors, care and outcomes during a contagion; and are instrumental factors in the 
control of transmission. The following discussion is inclusive of data obtained by this author in 
regard to age, gender and obesity, and the corresponding relationship these variables have to 
infection and case fatality rates. COVID-19 patient data, from six Colorado counties: two of 
which are rural (Weld and Morgan); two of which are large per capita urban counties (Denver 
and El Paso); and two popular, year-round, tourist destination counties (Summit and Eagle) (also 




classified as rural), are briefly examined here, and related to findings applicable from this 
review.  
Origin, Lineage, Genome Analysis & Phylogenesis 
The ancestry and evolution of viruses define the basis of transmissibility. Studies support 
this claim by validating the presence of requisite genome regions; attesting that necessary and 
possible recombination events occur; verifying sequence identity; and enabling ultimately,  
deduction of phylogenetic origin/attributability to certain species. Phylogenetic analysis of 
SARS-CoV-1, and MERS (Biao et al., 2014), made apparent the bat species (while responsible 
as primary reservoirs for various coronaviruses) (Biao et al.; Lu et al., 2020), was not the primary 
human infector(s) per se. While bats in the Yunnan region were identified as relevant species for 
hosting a diverse range of coronaviruses, metagenomic analysis offered strong support that an 
additional host (i.e., palm civet), or viral co-infection was necessary, as in the case of SARS-
CoV-1 (Biao et al., 2014). This is also thought to be the case for some subtypes of influenza A. 
Essentially, animals infected by more than one virus, consequently harbor viral processes that 
through reassortment events, produce pathogens capable of infecting humans (Ypma et al., 
2013). Another prospect, identified by Biao et al. (2014), described two gap-filling viruses; 
viruses that could bridge the gap from bat to human in the presence of a viral co-infection and 
recombinant events, within the animal host. Such findings suggest that bat to human 
transmission is feasible from select hosts that have been co-infected when certain genomic 
conditions are met, but further studies are necessary to confirm the prevalence and likelihood of 
this modality. 
The evolution of a virus (mutation and recombination) is closely associated with its 
distribution and occurrence in a population (Ypma et al., 2013). Thus, when SARS-CoV-2 struck 




in early winter 2019, scientists employed rapid genomic sequencing of an infected patient 
population (Lu et al., 2020) to gain insight into evolutionary and transmission relationships. 
When they analyzed the samples, findings conferred very close identity among the patients 
sampled (99.98% identical), indicating few recombinant events. Findings in regard to possible 
genomic mutations were similarly reported from To et al. (2020), in their systematic sampling of 
a COVID-19 cohort of patients in Jan/Feb. These studies are significant, as they confirm the 
outbreaks were identified in early stages. Additionally, similarities were found among the 
genomes of the COVID-19 patients when referenced against virus nucleotide sequences 
available via the genetic sequence database, GenBank (Lu et al., 2020). Closely related viruses 
found to be of bat ancestry directed evolutionary origin, while also indicating significant 
differences between SARS-CoV-1 and the current SARS-CoV-2 (Lu et al., 2020). The 
confirmed genomic similarities among afflicted patients early on, improves epidemiologic 
surveillance and timescale estimates of the contagion; while advising researchers and health 
officials of animal and associated geographic locations/ecology in need of monitoring; and 
potential public health interventions. 
Zoonosis and Intermediate Hosts 
While decades of research have established the preponderance of emerging infectious 
diseases as attributable to animal origins (Morse et al., 2012), an intermediate species is 
considered requisite for the diseases of consideration in this review, as evidenced by the genomic 
and evolutionary rationale. In the case of SARS-CoV-2, a likely conclusion based on research of 
the aforementioned contagions (Biao et al., 2014; Chan et al., 2020; Lu et al., 2020; van 
Doremalen et al., 2014; Zhao et al., 2019), is that the spillover from animal to humans is credited 
to an exotic species sold at the Wuhan market. More specifically, this animal likely contracted 




the disease from a shared habitat in which one of the following potentially occurred. 
Contamination of a common water source shared by the reservoir animal (bat) and the 
intermediate (palm civet); introduction (by wildlife farmers), of the palm civets to a new region 
in which the carrier bats habituated; or carcass decay/fecal particulate contamination of 
communal environment by infected bats near or around food sources (i.e. fruit trees, insects, fish, 
or other small mammals). Subsequently, the handling and preparation of infected palm civets 
(i.e. via slaughter, cleaning and packaging), fomite contamination in the market, or human 
consumption, resulted in a spillover to humans. Once the jump to humans was established, 
sustained human to human transmission ensued. 
Viral Tropism 
As noted previously, and shown extensively in the research (Biao et al., 2014; Bourgonje 
et al., 2020; Hui et al., 2020; Lu et al., 2020; Tai et al., 2020; Zmora et al., 2014), certain 
conditions must be met for a virus to attach and enter candidate cells. The foundational research 
of SARS-CoV-1, MERS, and influenza, facilitated comparisons of genomic similarities and 
molecular characteristics encompassing concepts of transmission efficiency for SARS-CoV-2. 
Prior investigate studies and molecular level assays have enabled rapid determination and 
modeling of SARS-CoV-2 host tropism. Demonstrably, SARS-CoV-2 exhibits a 10-20 times 
stronger affinity to ACE2 receptors, than that of SARS-CoV-1. This attribute is suspect as a 
reason for increased transmission efficiency among cells targeted by SARS-CoV-2 (Bourgonje et 
al., 2020; Tai et al., 2020). As these ACE2 receptors are expressed by so many cells and tissues 
throughout the body, tissue analyses reveal the pathogenesis respective of organ systems to 
scientists. Additionally, findings may differ in various populations (i.e. race/ethnicity, gender, 
age groups, underlying co-morbidities), and potentially offer additional information for scientists 




to treat on an organ system-level basis. Future studies specific to race/ethnicity and chromosomal 
expression of ACE2 receptors, may offer insight into protective mechanisms respective to 
differences among distinct segmentations of the population.  
Transmission Dynamics 
The infectious impact on host, and transmission dynamics of SARS-CoV-2 rely heavily 
on select organ pathogenesis and consequent propagated viral loads. Once habituated in the host 
cells, organs are affected based on both intrinsic and extrinsic processes of the host itself. 
Numerous non-structural proteins of coronaviruses have the capability to drastically alter 
intrinsic processes such as a host’s innate immune response. These proteins damage cells, 
inhibiting host immune response, augmenting expression of cytokines, masking viral 
identification by innate immune cells, and obstructing host RNA translation to mention a few 
(Astuti &Ysrafil, 2020). Concomitantly, due to interruption of inherent ACE2 functioning, there 
is dysregulation of metabolic and endocrine pathways which results in heightened inflammatory, 
and respiratory process exacerbation (Bourgonje et al., 2020; Kwon & Pessin, 2013). It follows, 
that in moderate and severe cases, the upper and lower respiratory tracts, where ACE2 receptors 
are exceedingly expressed, are susceptible to significant injury, ranging from cough, shortness of 
breath and dyspnea, to full-blown, acute respiratory distress (ARDS), requiring ventilatory 
support (due to profound inadequate gas exchange). Such aggravation is in line with the 
pneumonia described by researchers and clinicians reporting on SARS-CoV-2 (Bourgonje et al., 
2020; Hui et al., 2020; Zou et al., 2020). 
As discussed, and shown in the literature, the spread and promotion of SARS-CoV-2 is 
highly contingent on respiratory processes as is the case for SARS-CoV-1, MERS, and influenza. 
Abounding replication competence in the bronchus and colorectal cells (Bourgonje et al., 2020; 




Hui et al., 2020), promotes mechanisms of transmission consistent primarily of droplet (> 5-
10 μm in diameter), aerosol (< 5 μm in diameter), and oral-fecal shedding (i.e. coughing, 
sneezing, talking, breathing, stool and fomite contamination). While eccrine sweat glands also 
express ACE2 receptors, there was little information found, as to whether SARS-CoV-2 could be 
spread via shedding from an infected person’s sweat. Additional studies to investigate this 
modality might offer crucial information either in support or defense of keeping certain indoor 
exercise facilities/activities open during the pandemic, so long as other recommended 
precautionary measures are implemented.  
It is difficult to accurately ascertain how infectious asymptomatic carriers may be (given 
they may not be accurately identified), but notably, their shedding profile mimics that of 
symptomatic carriers (Zou et al., 2020). Also, given the high estimate proportion of 
asymptomatic infections (at present the current best estimate is 40%, CDC, 2020c), a SI of 7 
days, and determined early peak viral shedding (within the first week of the illness) (To et al., 
2020; Zou et al., 2020), transmission efficiency of SARS-CoV-2 is apparently agile. The fact that 
estimates for R0 vacillate so greatly, is likely due in part, to inconsistent social, behavioral, and 
travel restrictive measures (Li et al., 2020); poor compliance, and incomplete contact tracing. 
Given the assumption that SARS-CoV-2 will continue to circulate in the U.S. for at least the next 
several months, should restrictive measures and compliance continue in a status quo fashion, it is 
reasonable to estimate that the average asymptomatic carrier, could potentially infect between 2 
and 5 people during their period of contagiousness; more if it comes to light that viral shedding 
more frequently occurs for several weeks post-initial infection (or symptom presentation) as 
noted by To et al., (2020).  




The risk of transmission is more likely given the greater amount of time and proximity of 
infector to infectee (Lei et al., 2018; Wang et al., 2020). This finding is supported by the number 
of affected hospital workers in the case of MERS (Corman et al., 2014), and SARS-CoV-1 (Chan 
et al., 2011; Corman et al., 2014) outbreaks, and is indicated as being a considerable risk factor 
in SARS-CoV-2. Data shows that pocket outbreaks seen in various facilities (in which 
residents/workers are in close proximity with infected individuals) in Colorado, have hotspots in  
healthcare (skilled nursing facilities), assisted living facilities, “other” settings (i.e. food/meat 
processing plants), and prison/jails (see Appendix B, Figure 1) (CDPHE Open Data, 2020c). For 
the counties examined by this author, the number of outbreaks are noted highest in the counties 
housing the two largest urban cities in Colorado (the city of Denver, Denver County; and 
Colorado Springs, located in El Paso County); followed by Weld and Morgan counties, both of 
which experienced large outbreaks in meat packing plants (these plants were kept open early in 
the pandemic, despite most workplace closures as they were designated “essential”; temporary 
closures did occur following facility outbreaks). 
Immune Response and Patient Symptomology and Diagnosis 
Advancement to a severe form of SARS-CoV-2 is reported between 10-20 percent of 
cases (Bourgonje et al., 2020). Among others mentioned, contributory variables include: 
underlying comorbidities, gender, and individual immune response. The presence of one or more 
of the following: diabetes mellitus (DM), hypertension (HTN), vascular disease, chronic 
respiratory disease and cancer were noted as often accompanying forms of the disease that 
progressed (Bourgonje et al., 2020; Guan et al., 2020; To et al., 2020); requiring intensive care 
hospitalization, or resulting in death. ACE2 expression or inhibition due to different disease 




processes and their corresponding drug management, may offer evidence for improved 
management of complex patients infected with COVID-19 in future studies. 
An increased risk for severity is noted with corresponding increase in age (over the age of 
60) (Bourgonje et el., 2020; Guan et al., 2020). While this may be due to a decrease in immune 
response related to age, it may also be a consequence of long-term inflammation, sub-clinical 
processes, or underlying disease gradually progressive with age. This finding is supported by 
data examined by this author in analysis of select Colorado counties affected by COVID-19. Of 
the patients affected over the age of 60, the percentage who were hospitalized or died increased 
dramatically with age. As shown in Appendix B, Figure 2 (CDPHE Open Data, 2020b), 11% of 
the population of Coloradoans is made up of a population segment aged 60-69 years. Of that 
segment, 13% were hospitalized at the time of this writing, and 13% of those affected also 
subsequently died. When the 70-79-year bracket (which comprises 6% of the CO population) 
was evaluated, 8% were noted as hospitalized, and of those affected 24% died. For the 80+ year 
age group (comprising of 3% of the CO population), the percentage hospitalized was also 8%; 
however, the percentage of those affected who died, was 54%. That equates to a two-fold 
increased risk of death for the first 10 years increase in age; which more than doubles again for 
the next 10-year increase in age.  
ACE2 plasma concentration levels, evidenced to be higher in men (Bhatie, Sekhon & 
Kaur, 2014; Bourgonje et al., 2020), may lend credence as to why the death and infection rates 
are reported as higher in men. An intrinsic disparity may be due to ACE2 gene expression, or the 
effects of the reproductive system and sex hormones, by way of  hormone receptors on immune 
cells (Bhatie et al., 2014).  The effect of behavioral habits may also play a role (i.e. smoking;  
Smith et al., 2020).  




The gender component, is similarly supported by the data retrieved and examined by this 
author. As seen in Appendix B, Figure 3 (CDPHE Open Data, 2020c), the percentage of 
Colorado males affected is an average of 5.2% higher. Additionally, of the population of 
Colorado males affected who die is 5.3% higher on average than females. 
A risk factor commonly mentioned in the literature as contributory to COVID-19 
severity, and in itself a risk factor for many diseases (including influenza) (Bourgonje et al., 
2020), is obesity. As discussed previously, increased obesity (BMI >25kg/m2) in patients 
resulted in potentially increased severity of symptoms, likelihood of intensive care admission, 
need for invasive therapies and death (Bourgonje et al., 2020) While obesity was not reported 
available data for the patients affected during this author’s study, county obesity data was pulled 
to evaluate against the county CFR and county infection rate (per 100K people) for COVID-19. 
What can be seen from this analysis in Appendix B, Figure 4 (CDPHE Open Data, 2020a; 
CDPHE Open Data, 2020d), is a significant relationship between people over the age of 18 and 
obese (BMI>30), and the CFR (p-value =.021734) for the counties of interest. There is not a 
significant correlation between obesity reported for people 18 years and older and rate of 
infection (p-value > .05); The positive correlation for CFR and obesity suggests that of the 
population who are obese, should they contract COVID-19, there is a high risk of dying, while 
the second metric indicates that the chance of contracting COVID-19 is not significantly 
increased due to obesity. The rationale discussed previously supporting inflammatory 
potentiation due to visceral fat adipokines, and the delicate regulatory balance they are 
responsible for, supports the likelihood of increased severity/death for obese patients (Bourgonje 
et al., 2020; Kwon & Pessin, 2013); however, further studies are needed to validate this 
supposition. 




Additional studies are also merited to evaluate brain tissue involvement in SARS-CoV-2, 
as indicated by reported neurologic symptoms. Symptoms such as loss of taste (ageusia) and 
smell (anosmia), suggest involvement of cells central to those regions of the brain (Bourgonje et 
al., 2020), but little information could be found in the literature relative to analysis of brain tissue 
and SARS-CoV-2.  
From the research reviewed, it is apparent that early and accurate diagnosis requires 
additional diagnostics both due to the overlap of symptoms among the similarly presenting 
diseases of SARS-CoV-2 and influenza, and the reported sensitivity of RT-PCR testing (Wang et 
al., 2020; Watson et al., 2020). Repeat testing in the presence of reported symptoms, with a test 
from a different manufacturer, or follow-up with a serology test for antibodies seems merited. 
CT scans reveal some essential features of SARS-CoV-2 patients when compared with CT scans 
from patients affected with influenza (Bourgonje et al., 2020; Guan et al., 2020; To et al., 2020; 
Wang et al., 2020). While CT scans are an additional cost, the adjunct use when indicated, may 
actually contribute to control of spread, cost containment (long-term), and improved quality of 
care. 
Viral Persistence and Stability 
Research reported on conditions and modes of transmission via inanimate 
objects/surfaces most favorable for coronavirus persistence suggests the following: higher 
probability of infection from fomites, contaminated plastic and stainless-steel surfaces, air-
conditioned or poorly ventilated (including recycled air) environments, and relative humidity of 
40-50% (Chan et al., 2011; Lei et al., 2018; Ong et al., 2020; van Doremalen et al., 2020). Viral 
persistence of SARS-CoV-2 was shown to be stable for several hours both as an airborne 
pathogen, and for days as a surface contaminant (van Doremalen et al., 2020). Given the 




established stability of SARS-CoV-2, how equipment is used, and under what type of exposure 
equipment could be contaminated, is a necessary consideration in the handling of this pandemic. 
Additionally, measures to counteract stability and viability of the virus can be further explored 
given the knowledge obtained via these studies. Deterrent measures targeting temperature, 
humidity, air filtration, asepsis, or use/integration of materials shown to be non-supportive of 
SARS-CoV-2 growth (i.e. copper) (van Doremalen et al., 2020); require further investigation and 
consideration. 
Therapy and Treatments 
As previously discussed, a viable vaccine is presently unavailable, yet hopeful prospects 
are reported in various phase trial stages for a number of pharmaceutical manufacturers 
(Regulator Affairs Professionals Society (RAPS), 2020). Thus, targeting the spread of SARS-
CoV-2 requires an amalgamation of controls. Therapy described previously is largely supportive, 
while preventative measures are the first line of defense. Measures in the context of masks, hand 
sanitizer, good hand hygiene and social distancing, avoidance of public gatherings (either in or 
outdoors), limiting trips to public venues, and refraining from un-necessary travel. Shown in 
Appendix B, Figures 5-7 (CDPHE Open Data, 2020a; Guidotti & Ardia, 2020), are the various 
restrictive measures implemented by local Colorado governments, corresponding trends of 
positive cases, and case fatality rates. The restrictive measures assessed for this analysis relate to 
school closing, work closing and stay at home restrictions/recommendations. Figure 5 
demonstrates the timeline relative to the number of tests performed (orange), and the number of 
confirmed positive cases (blue); (confirmed positive tests/county population * 100K people = 
infection rate), and corresponding restrictive measures. Figure 6 annotates a timeline of 
closures/orders during the early stages of the outbreak. Restrictive measures are numerically 




categorized from 0-3; 0 indicates no measures in place; and 3 indicates most restrictive measures 
(see associated key for graphs). In Figure 7, all counties of interest are depicted; case fatality rate 
is noted to peak on May 21st for the example highlighted (Denver), then slowly levels 
off/declines, despite the high reported number of positive cases. This finding may be due to an 
increased compliance of restrictive measures by the at-risk population (60+), for which the death 
rate is significantly higher, thereby limiting exposure and incidence. To validate this claim, 
mobility data and contact tracing for that population would be necessary additional variables to 
evaluate. 
Conclusion 
The examination of prior disease outbreaks, attributed to SARS-CoV-1, MERS, and 
influenza, may assist in various ways to control and contain the transmission of SAR-CoV-2 by 
the scientific community, as well as the general public. While information aggregation and 
assimilation are the foundation for theory formulation, drug development, and medical 
intervention; increased awareness and promoted knowledge serve to shape personal and public 
reaction to emerging infectious diseases, and better an individual’s ability to respond 
accordingly. While response of the scientific and medical communities is dictated largely by 
biological factors, a founded understanding by the general public, largely mitigates fear and 
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 PRISMA diagram shown below outlining methodology for literature search.  
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Note: Adapted (and revised) from: Moher, D., Liberati, A., Tetzlaff, J., & Altman, D.G., The PRISMA Group. (2009). Preferred Reporting 
Items for Systematic Reviews and MetaAnalyses: The PRISMA Statement. PLoS Med 6(7): e1000097. doi:10.1371/journal.pmed1000097 
 
Total articles identified through 
database searching: 
 n=286 
Database          # of articles 
ASC  57 
CINAHL 21 
PubMed 34 
Scopus  174 
 
Number of articles remaining 
following the removal of 
duplicates: n=209 
Number of articles remaining 
after title and abstract review: 
n=49 
Number of articles remaining 
following full text review: 
n=31 
Final inclusion after appraisal: 
n=31 
Additional articles identified 




Articles excluded based 
on title and abstract: 
n=160 
Full text articles excluded 
with reasons: n=18 
• Reviews n=5; 
systematic reviews=7 
• Not yet accepted for 
publication n=1 
• Irrelevant n=5 




Included graphs for Colorado counties depicting Eagle, El Paso, Denver, Morgan, Summit and Weld, 
relevant to capstone project for HIN 785. This descriptive study is used to evaluate the correlative strength of 
numerous variables with the positive case rate/infectious rate and case fatality rate (CFR) of COVID-19, to 
potentially improve awareness and population segment outcome(s) through risk factor(s) early identification. 
Also, to evaluate how certain early interventions or lack thereof, impact the counties of focus. 
 
Figure 1 
County and Localized Setting of Outbreak 
 
 
Note. Active outbreaks are represented in blue, resolved outbreaks represented in orange. The intensity 
of the color corresponds to the size of the outbreak. Most notably affected are Healthcare, skilled nursing 
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facilities, followed by Healthcare, assisted living residences, “other”, most notably reported though meat 








Note. The data reflective on this graph is representative of all age groups in Colorado and the percentage 
each age group comprises of the Colorado population (represented in gray). A sharp increase in the 
percentage of deaths can be seen beginning at the 60-69 year-age group. For example, of the age group 
population described (i.e. 80+, the group comprising 3% of the Colorado population), the deaths 
(represented by the red line), make up 54 % of the deaths and 8% of the cases (represented by the blue 
line). Data retrieved from CDPHE https://data-cdphe.opendata.arcgis.com/datasets/cdphe-covid19-
state-level-open-data-repository 





Percentage of Males and Females Affected by Cases and Deaths 
 
 
Note. Of the percentage of males affected for the month of April, 17% of the cases making up the female 
segment died, while 24% of the cases representative of the male segment died. The graph shows that males have 
a 5.3% higher rate of death than females on average, and an average of 5.2% higher rate of overall cases. Data 














Obesity and 18+ Years of Age for Counties of Interest vs. CFR, and Infection Rate/100K People 
 
 
Note: The graph on the left demonstrates the relationship between people in the population for the 
counties of interest, who are considered obese (BMI>30), age 18 years+, and the case fatality rate; the p-
value is .0201734, which is considered significant. The graph on the right, demonstrates the rate of  
infections per 100K (for the counties of interest), and the percentage of people in the population 
considered obese and age 18 years+; the p-value is non-significant (p-value=.515065). Data retrieved from 
CDPHE https://data-cdphe.opendata.arcgis.com/datasets/obesity-in-adults-colorado-brfss-2014-2017-












Total Number of Daily Tests and Positive Cases (Breakout Counties of Interest) with Average Number of 
Cases and 95% Confidence Interval 
 
 
Note. Graph depicts tooltip for the date in which shelter-in-place orders expired and many people returned to 
work for given counties (only Denver is shown in the above example). The rate of testing is shown in orange 
relative to confirmed positive cases shown in blue. Restrictions are numerically categorized as 0-3, with 0=no 
measures, and 3=most restrictive.  
Key: 
school_closing: 0=No measures; 1=Recommend Closing; 2=Require closing (only some levels or 
categories, i.e. just high school, or just public schools; 3=Require closing all levels. 
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workplace_closing: 0=No measures; 1=Recommend closing or work from home; 2=Require closing 
some categories or sectors of workers; 3=Require closing or work from home all but essential 
workplaces (i.e. grocery stores, doctors). 
stay_home_restrictions: 0=No measures; 1=Recommend not leaving house; 2=Require not leaving the 
house with exceptions for daily exercise, grocery shopping and “essential” trips; 3=Require not leaving 
house with minimal exceptions (i.e. allowed to leave only once every few days, or only one person can 
leave at a time, etc.). Data and above key retrieved from COVID-19 Data-hub  




Total Number of Daily Tests and Positive Cases (Breakout Counties of Interest) 
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Note.  Graph depicts the number of positive cases for the county of Denver; date on which full stay-at-home 
orders went into place; when stay and home and workplace restrictions were dropped to recommended stay at 
home (2); and subsequent “safer-at-home” and workplace decrement in restrictions to (1). Median number of 
cases (4153) for county is noted as very close to average number of cases (3825) reported with 95% CI. Data 




Total Number of Daily Tests and Positive Cases (All Counties of Interest) 
 
Note. A high-level view of all counties of interest with average confirmed cases and 95% CI for period of 
March 18 – July 4, 2020. Tooltip indicates corresponding measures observed, number of deaths for respective 
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county and current case fatality rate. CFR peaks (in the above example for Denver), on May 21st, shortly before 
the shelter-in-place order expires (May 26th, 2020). Data and key retrieved from COVID-19 Data-hub  
https://covid19datahub.io/articles/data.html and CDPHE https://data-
cdphe.opendata.arcgis.com/datasets/colorado-covid-19-positive-cases-and-rates-of-infection-by-county-of-
identification?geometry=-121.075%2C35.977%2C-90.027%2C41.950 
